0001062993-21-008352.txt : 20210908 0001062993-21-008352.hdr.sgml : 20210908 20210908120643 ACCESSION NUMBER: 0001062993-21-008352 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210903 FILED AS OF DATE: 20210908 DATE AS OF CHANGE: 20210908 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: TUMOLO ANNETTE CENTRAL INDEX KEY: 0001717996 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-07928 FILM NUMBER: 211241275 MAIL ADDRESS: STREET 1: C/O BIO-RAD LABORATORIES, INC. STREET 2: 1000 ALFRED NOBEL DRIVE CITY: HERCULES STATE: CA ZIP: 94547 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIO-RAD LABORATORIES, INC. CENTRAL INDEX KEY: 0000012208 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] IRS NUMBER: 941381833 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1000 ALFRED NOBEL DRIVE CITY: HERCULES STATE: CA ZIP: 94547 BUSINESS PHONE: 5107247000 MAIL ADDRESS: STREET 1: 1000 ALFRED NOBEL DRIVE CITY: HERCULES STATE: CA ZIP: 94547 FORMER COMPANY: FORMER CONFORMED NAME: BIO RAD LABORATORIES INC DATE OF NAME CHANGE: 19920703 4 1 form4.xml STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES X0306 4 2021-09-03 0000012208 BIO-RAD LABORATORIES, INC. BIO BIOB 0001717996 TUMOLO ANNETTE C/O BIO-RAD LABORATORIES, INC. 1000 ALFRED NOBEL DRIVE HERCULES CA 94547 0 1 0 0 Executive Vice President Bio-Rad A Common Stock 2021-09-03 4 M 0 557 .00 A 3939.3476 D Bio-Rad A Common Stock 2021-09-03 4 F 0 252 819.70 D 3687.3476 D Bio-Rad A Common Stock 2021-09-04 4 M 0 600 .00 A 4287.3476 D Bio-Rad A Common Stock 2021-09-04 4 F 0 298 819.70 D 3989.3476 D Bio-Rad A Common Stock 2021-09-05 4 M 0 600 .00 A 4589.3476 D Bio-Rad A Common Stock 2021-09-05 4 F 0 298 819.70 D 4291.3476 D Restricted Stock Units 0 2021-09-03 4 M 0 557 0 D Bio-Rad A Common Stock 557 1671 D Restricted Stock Units 0 2021-09-04 4 M 0 600 0 D Bio-Rad A Common Stock 600 1200 D Restricted Stock Units 0 2021-09-05 4 M 0 600 0 D Bio-Rad A Common Stock 600 600 D Shares of Class A common stock acquired on the vesting of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. On September 3, 2019, the reporting person was granted 2,784 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date. On September 4, 2018, the reporting person was granted 3,000 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date. On September 5, 2017, the reporting person was granted 3,000 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date. /s/ Annette Tumolo 2021-09-07